Aprea Therapeutics CEO Christian Schade's 2020 pay rises 6% to $3.9M
Aprea Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Aprea Therapeutics reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, three executives at Aprea Therapeutics received on average a compensation package of $2.6M, a 16% increase compared to previous year.
Average pay of disclosed executives at Aprea Therapeutics
Christian S. Schade, Chief Executive Officer, received $3.9M in total, which increased by 6% compared to 2019. 80% of Schade's compensation, or $3.1M, was in option awards. Schade also received $283K in non-equity incentive plan and $515K in salary.
Eyal C. Attar, Chief Medical Officer, received a compensation package of $2M, which increased by 66% compared to previous year. 68% of the compensation package, or $1.3M, was in option awards.
Scott M. Coiante, Chief Financial Officer, earned $1.9M in 2020, a 3% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2021.